Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - olanzapine embonate monohydrate 483mg equivalent to 210 mg olanzapine, also known as olanzapine pamoate monohydrate - powder for injection - 210 mg - active: olanzapine embonate monohydrate 483mg equivalent to 210 mg olanzapine, also known as olanzapine pamoate monohydrate excipient: carmellose sodium mannitol polysorbate 80 water for injection - zyprexa relprevv is a long-acting injectable formulation of olanzapine indicated for acute and maintenance treatment of schizophrenia in adults. the effectiveness of zyprexa relprevv is consistent with the established effectiveness of orally administered olanzapine for acute or maintenance treatment of schizophrenia.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - olanzapine embonate monohydrate 690mg equivalent to 300 mg olanzapine - powder for injection - 300 mg - active: olanzapine embonate monohydrate 690mg equivalent to 300 mg olanzapine excipient: carmellose sodium mannitol polysorbate 80 water for injection - zyprexa relprevv is a long-acting injectable formulation of olanzapine indicated for acute and maintenance treatment of schizophrenia in adults. the effectiveness of zyprexa relprevv is consistent with the established effectiveness of orally administered olanzapine for acute or maintenance treatment of schizophrenia.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - olanzapine embonate monohydrate 931mg equivalent to 405 mg olanzapine - powder for injection - 405 mg - active: olanzapine embonate monohydrate 931mg equivalent to 405 mg olanzapine excipient: carmellose sodium mannitol polysorbate 80 water for injection - zyprexa relprevv is a long-acting injectable formulation of olanzapine indicated for acute and maintenance treatment of schizophrenia in adults. the effectiveness of zyprexa relprevv is consistent with the established effectiveness of orally administered olanzapine for acute or maintenance treatment of schizophrenia.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - hepatitis b immunoglobulin, human 220 iu/ml (from us plasma) - solution for injection - 220 iu/ml - active: hepatitis b immunoglobulin, human 220 iu/ml (from us plasma) excipient: glycine water for injection - hepatitis b immunoglobulin (human) is indicated for post-exposure prophylaxis in persons who did not receive prior vaccination, or whose prior vaccination regimen is incomplete or when the antibody level is inadequate i.e. (human) with hepatitis b vaccine will provide both short and long-term protection. this post exposure prophylaxis should be considered following either parenteral exposure, direct mucous membrane contact, oral ingestion, sexual exposure to an hbsag-positive person and for infants hepatitis b immunoglobulin (human) can also be considered for haemodialysis patients and receptors of certain blood products unable to develop adequate immune protection.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - normal immunoglobulin 50 mg/ml - solution for infusion - 50 g/l - active: normal immunoglobulin 50 mg/ml excipient: sorbitol water for injection - flebogamma 5% dif is indicated for: replacement therapy in: primary immunodeficiency syndromes such as: - congenital agammaglobulinaemia and hypogammaglobulinaemia - common variable immunodeficiency - severe combined immunodeficiency - wiskott aldrich syndrome myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections. children with congenital aids and recurrent infections. immunomodulation idiopathic thrombocytopenic purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count. guillain barr? syndrome. allogeneic bone marrow transplantation.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - normal immunoglobulin 100 mg/ml - solution for infusion - 100 g/l - active: normal immunoglobulin 100 mg/ml excipient: sorbitol water for injection - replacement therapy indications: - primary immunodeficiency (pi) diseases - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulation indications: - idiopathic thrombocytopaenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count. - guillan barre syndrome. - kawasaki disease.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - chorionic gonadotrophin 500 [iu] (material -hormone hcg ex netherlands,belgium);   - injection with diluent - 500 iu - active: chorionic gonadotrophin 500 [iu] (material -hormone hcg ex netherlands,belgium)   excipient: gelatin sodium chloride

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - human chorionic gonadotrophin highly purified 5 [iu] (material -hormone hcg ex netherlands,belgium); sodium chloride 9mg - injection with diluent - 5 iu - active: human chorionic gonadotrophin highly purified 5 [iu] (material -hormone hcg ex netherlands,belgium) excipient: gelatin mannitol polysorbate 20 water for injection active: sodium chloride 9mg excipient: water for injection

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - rimexolone 10 mg/ml - eye drops, suspension - 1 % - active: rimexolone 10 mg/ml excipient: benzalkonium chloride carbomer disodium edetate hydrochloric acid mannitol polysorbate 80 purified water sodium chloride sodium hydroxide

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - travoprost 0.004%{relative} - eye drops, solution - 0.004% w/v - active: travoprost 0.004%{relative} excipient: boric acid hydrochloric acid hydrogenated castor oil propylene glycol purified water sodium hydroxide sorbitol zinc chloride - indicated to decrease elevated intraocular pressure in ocular hypertension and open-angle glaucoma.